Perioperative management of the patient with rheumatoid arthritis

Clinics in Podiatric Medicine and Surgery

Volumn 27, Issue 2, 2010, Pages 235-242

  Jacobs, Allen Mark ^a  

^a NONE   (United States)

Author keywords

Complications; Medications; Perioperative management; Rheumatoid arthritis

Indexed keywords

ABATACEPT; ACETYLSALICYLIC ACID; ACTMERA; ADALIMUMAB; AZATHIOPRINE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; DALTEPARIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ENOXAPARIN; ETANERCEPT; GLUCOCORTICOID; HYDROCORTISONE; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR BETA INHIBITOR; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; WARFARIN;

ABNORMAL LABORATORY RESULT; DEEP VEIN THROMBOSIS; DRUG DOSE REDUCTION; DRUG MECHANISM; FOOT SURGERY; FRACTURE NONUNION; HIGH RISK POPULATION; HUMAN; IMMOBILIZATION; INFECTIOUS COMPLICATION; LOW DRUG DOSE; NEUROLOGIC DISEASE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SOFT TISSUE DISEASE; SPINE DISEASE; TENDON DISEASE; VASCULAR DISEASE;

ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ASPIRIN; CERVICAL VERTEBRAE; GLUCOCORTICOIDS; HUMANS; IMMOBILIZATION; LABORATORY TECHNIQUES AND PROCEDURES; METHOTREXATE; PENICILLAMINE; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; SPINAL DISEASES; TUMOR NECROSIS FACTOR-ALPHA; VENOUS THROMBOSIS;

EID: 77952763226     PISSN: 08918422     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpm.2010.02.001     Document Type: Review

References (18)

1. Kelley J.T., Conn D.L. Perioperative management of the rheumatic disease patient. Bull Rheum Dis 2002, 51(6):l-7.
2. Lind S.E. The bleeding time does not predict surgical bleeding. Blood 1991, 77:2547.
3. Gerwirtz A.S., Miller M.L., Keys T.F. The clinical usefulness of the preoperative bleeding time. Arch Pathol Lab Med 1996, 120:353-356.
4. Connelly C.S., Panush R.S. Should nonsteroidal anti-inflammatory drugs be stopped before elective surgery?. Arch Intern Med 1991, 151:1963-1966.
5. Robinson C.M., Christie J., Malcolm-Smith N. Nonsteroidal antiinfiammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty. J Arthroplasty 1993, 8:607-610.
6. Coursin D.B., Wood K.E. Corticosteroid supplementation for adrenal insufficiency. JAMA 2002, 287:236.
7. Lamberts S.W., Bruining H.A., de Jong F.H. Corticosteroid therapy in severe illness. N Engl J Med 1997, 337:1285-1292.
8. Perhala R.S., Wilke W.S., Clough J.D., et al. Local infectious complications following knee joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum 1991, 34:146.
9. Kasdan M.L., June L. Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand. Orthopedics 1993, 16:1233-1235.
10. Grennan D.M., Gray J., Loudon J., et al. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 2001, 60:214-217.
11. Bibbo C. Wound healing complications and infection following surgery for rheumatoid arthritis. Foot Ankle Clin 2007, 12(3):509-524.
12. Lee R.H., Efron D.T., Tantry U., et al. Inhibition of tumor necrosis factor-alpha attenuates wound breaking strength in rats. Wound Repair Regen 2000, 8:547-553.
13. Dixon W., Watson K., Lunt M., et al. Serious infection rates, including site-specific and bacterial intracellular infection rates, in rheumatoid arthritis patients treated with anti-TNFαtherapy: results from the British Society for Rheumatology Biologies Register (BSRBR). Arthritis Rheum 2006, 54:2368-2376.
14. Listing J., Strangfeld A., Kary S., et al. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 2005, 52(l l):3403-3412.
15. Crawford M., Curtis J.R. Tumor necrosis factor inhibitors and infection complications. Curr Rheumatol Rep 2008, 10:383-389.
16. Bibbo C., Anderson R.B., Davis W.H. Injury characteristics and the clinical outcome of subtalar dislocations: a clinical and radiographic analysis of 25 cases. Foot Ankle Int 2003, 24(2):158-163.
17. Reize P., Ina Leichtle C., Leichtle U.G., et al. Long-term results after metatarsal head resection in the treatment of rheumatoid arthritis. Foot Ankle Int 2006, 27(8):586-590.
18. Anderson T., Linder L., Rydholm U., et al. Tibio-talocalcaneal arthrodesis as a primary procedure using a retrograde intramedullary nail: a retrospective study of 26 patients with rheumatoid arthritis. Acta Orthop 2005, 76:580-587.